Categories AlphaGraphs, Earnings, Health Care
BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues.
Total revenue declined 7% year-over-year to $2.30 billion in the March quarter. For the full year of 2024, the company expects revenues to decline in the low-to-mid-single digit percentage and projects adjusted earnings per share in the range of $15.00 to 16.00.
Net income attributable to Biogen was $393.4 million or $2.70 per share in Q1, compared to $387.9 million or $2.67 per share in the prior-year period. Adjusted earnings moved up 8% annually to $3.67 per share in the first quarter.
Prior Performance
Most Popular
Home Depot (HD) Q1 2024 Earnings: Key financials and quarterly highlights
The Home Depot (NYSE: HD) reported first quarter 2024 earnings results today. Sales decreased 2.3% year-over-year to $36.4 billion. Comparable sales decreased 2.8%. Net earnings were $3.6 billion, or $3.63 per share, compared
Applied Materials (AMAT) is set to report Q2 results. Here’s what to expect
Applied Materials, Inc. (NASDAQ: AMAT), a leading supplier of semiconductor fabrication equipment, has successfully navigated through market challenges, aided by its diversified customer base and continued innovation. The tech firm
What to expect when Lowe’s Companies (LOW) reports Q1 2024 earnings results
Shares of Lowe's Companies, Inc. (NYSE: LOW) were down over 1% on Monday. The stock has gained over 4% year-to-date. The home improvement retailer is scheduled to report its first
